Technical Analysis for CRDL - Cardiol Therapeutics Inc

Grade Last Price % Change Price Change
grade B 6.37 5.29% 0.320
CRDL closed up 5.29 percent on Thursday, March 21, 2019, on 2.51 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical CRDL trend table...

Date Alert Name Type % Chg
Mar 21 Crossed Above 50 DMA Bullish 0.00%
Mar 21 Pocket Pivot Bullish Swing Setup 0.00%
Mar 21 Wide Bands Range Expansion 0.00%
Mar 21 Oversold Stochastic Weakness 0.00%
Mar 20 Fell Below 50 DMA Bearish 5.29%
Mar 20 Wide Bands Range Expansion 5.29%
Mar 20 Oversold Stochastic Weakness 5.29%
Mar 19 Crossed Above 50 DMA Bullish -1.09%
Mar 19 Pocket Pivot Bullish Swing Setup -1.09%
Mar 19 Wide Bands Range Expansion -1.09%

Older signals for CRDL ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cardiol Therapeutics Inc is a Canada-based company engaged in the pharmaceutical business sector. The Company is focused on the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for heart failure and cancer. It has research programs focused on development of nanotherapeutics to treat heart failure underway. The Company invests in development of formulations for three medical markets: commercializing a line of purity pharmaceutically-manufactured cannabidiol products in the market for medical cannabinoids; development of nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure, a cause of death and hospitalization, and pursuing an immunotherapeutics program commencing with a cancer immunotherapeutic in combination with cannabinoids for treating Glioblastoma Multiforme.
Cancer Drugs Organ Systems Analgesics Cannabinoids Pharmaceutical Business Sector
Is CRDL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.29
52 Week Low 4.05
Average Volume 55,735
200-Day Moving Average 0.0
50-Day Moving Average 6.2664
20-Day Moving Average 6.998
10-Day Moving Average 6.323
Average True Range 0.4938
ADX 21.21
+DI 27.2985
-DI 24.974
Chandelier Exit (Long, 3 ATRs ) 6.808599999999999
Chandelier Exit (Short, 3 ATRs ) 7.2314
Upper Bollinger Band 8.5275
Lower Bollinger Band 5.4685
Percent B (%b) 0.29
BandWidth 43.712489
MACD Line -0.0944
MACD Signal Line 0.0773
MACD Histogram -0.1717
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.720
Resistance 3 (R3) 7.717 7.263 7.495
Resistance 2 (R2) 7.263 6.920 7.265 7.420
Resistance 1 (R1) 6.817 6.707 7.040 6.820 7.345
Pivot Point 6.363 6.363 6.475 6.365 6.363
Support 1 (S1) 5.917 6.020 6.140 5.920 5.395
Support 2 (S2) 5.463 5.807 5.465 5.320
Support 3 (S3) 5.017 5.463 5.245
Support 4 (S4) 5.020